Main > ENDOCRINOLOGY > USA. E. Diab. 2>Glycemic Control>

---

USA. E. Diab. 2>Glycemic Control>'s subsections
(*) CA (GC) OK: 2016. 02.16
(*) CA (MACE) OK: 2020. 09.11
(*) EU (GC) OK: 2014. 11.21
(*) USA (GC) OK: 2014. 09.18.
(*) USA (MACE) OK: 2020. 02.21
>(GC) & MACE Risk Redn>GLP-1 Agonis
Company
Generic Name: Dulaglutide
GLP: Glucagon-Like Peptide
MACE: Major Adverse CV Event
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2021. 10.26.
RTM
RTM Web-Site

USA. E. Diab. 2>Glycemic Control>'s products
This section has no products